Rolf M. Zinkernagel | Academic Influence

Rolf M. Zinkernagel's AcademicInfluence.com Rankings

Rolf M. Zinkernagel

Biology

#284

World Rank

#518

Historical Rank

Immunology

#8

World Rank

#8

Historical Rank

biology Degrees

Download Badge

Biology

Rolf M. Zinkernagel's Degrees

Doctorate Medicine University of Basel
PhD Immunology University of Basel

Why Is Rolf M. Zinkernagel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Rolf Martin Zinkernagel AC is a professor of experimental immunology at the University of Zurich. Along with Peter C. Doherty, he shared the 1996 Nobel Prize in Physiology or Medicine for the discovery of how the immune system recognizes virus-infected cells.

(See a Problem?)

Rolf M. Zinkernagel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Functional role of type I and type II interferons in antiviral defense. (1994) (2580)
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice (1994) (1948)
MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. (1979) (1882)
Impaired immune and acute-phase responses in interleukin-6-deficient mice (1994) (1856)
Immune response in mice that lack the interferon-gamma receptor. (1993) (1612)
Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes (1993) (1335)
Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice (1991) (1300)
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. (2000) (1093)
Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen (1989) (1082)
Control of early viral and bacterial distribution and disease by natural antibodies. (1999) (947)
T-cell receptor Vβ use predicts reactivity and tolerance to Mlsa- encoded antigens (1988) (899)
On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? (1978) (887)
On immunological memory. (1996) (878)
Evidence for a differential avidity model of T cell selection in the thymus (1994) (784)
Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4 (1991) (783)
Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes (1998) (775)
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells (1993) (773)
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases (1989) (699)
Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene (1996) (697)
Immunology Taught by Viruses (1996) (681)
The influence of antigen organization on B cell responsiveness. (1993) (671)
Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. (1996) (665)
H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T- cell specificities are associated with structures coded for in H-2K or H-2D; (1975) (601)
Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo (1990) (595)
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells (1993) (582)
Decreased tumor surveillance in perforin-deficient mice (1996) (568)
Natural antibodies and complement link innate and acquired immunity. (2000) (539)
Antigen localisation regulates immune responses in a dose‐ and time‐dependent fashion: a geographical view of immune reactivity (1997) (529)
Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction (2001) (529)
Immune responses in interleukin-2-deficient mice. (1993) (503)
Immune surveillance against a solid tumor fails because of immunological ignorance. (1999) (495)
Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. (1991) (491)
A BIOLOGICAL ROLE FOR THE MAJOR HISTOCOMPATIBILITY ANTIGENS (1975) (475)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration (2004) (465)
Neutralizing antiviral B cell responses. (1997) (455)
A crucial role for B cells in neuroinvasive scrapie (1997) (444)
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease (2005) (432)
Virus‐specific major MHC class II‐restricted TCR‐transgenic mice: effects on humoral and cellular immune responses after viral infection (1998) (401)
H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus (1975) (382)
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes (1998) (378)
FTY720 Immunosuppression Impairs Effector T Cell Peripheral Homing Without Affecting Induction, Expansion, and Memory1 (2000) (368)
Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors (1995) (367)
Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice (1994) (366)
Self Antigens Expressed by Solid Tumors Do Not Efficiently Stimulate Naive or Activated T Cells: Implications for Immunotherapy (1997) (348)
Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies (2001) (346)
Complement facilitates early prion pathogenesis (2001) (345)
Dendritic Cells Induce Autoimmune Diabetes and Maintain Disease via De Novo Formation of Local Lymphoid Tissue (1998) (337)
Immune Defence in Mice Lacking Type I and/or Type II Interferon Receptors (1995) (329)
Antiviral antibody responses: the two extremes of a wide spectrum (2006) (319)
The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses (1995) (319)
Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides (1998) (306)
On natural and artificial vaccinations. (2003) (306)
Lower receptor avidity required for thymic clonal deletion than for effector T-cell function (1991) (301)
Visualization, characterization, and turnover of CD8+ memory T cells in virus-infected hosts (1996) (299)
Thymus and Lymphohemopoietic Cells: Their Role in T Cell Maturation in Selection of T Cells' H‐2‐Restriction‐Specificity and in H‐2 Linked Ir Gene Control (1978) (291)
Maternal antibodies, childhood infections, and autoimmune diseases. (2001) (287)
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. (1998) (287)
Antigen localization and migration in immunity and tolerance. (1998) (284)
PrP expression in B lymphocytes is not required for prion neuroinvasion (1998) (282)
Immunotherapy with Dendritic Cells Directed against Tumor Antigens Shared with Normal Host Cells Results in Severe Autoimmune Disease (2000) (281)
The discovery of MHC restriction. (1997) (277)
On the role of antigen in maintaining cytotoxic T-cell memory. (1996) (271)
Reduced Incidence and Delayed Onset of Diabetes in Perforin-deficient Nonobese Diabetic Mice (1997) (265)
The role of antibody concentration and avidity in antiviral protection. (1997) (259)
Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients (1988) (248)
Functional analysis of T lymphocyte subsets in antiviral host defense. (1987) (248)
CD8+ T cell‐mediated protection against an intracellular bacterium by perforin‐dependent cytotoxicity (1994) (245)
Regulation of the Immune Response by Antigen (2001) (244)
Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. (2000) (243)
T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS. (1994) (243)
T cell priming versus T cell tolerance induced by synthetic peptides (1995) (243)
Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. (1991) (240)
A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. (1997) (235)
Aggravation of viral hepatitis by platelet-derived serotonin (2008) (234)
Peptide-induced antiviral protection by cytotoxic T cells. (1991) (233)
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients (1988) (231)
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections (2003) (222)
Localization dose and time of antigens determine immune reactivity. (2000) (219)
Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression (1991) (219)
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen (1992) (218)
Dendritic Cells Efficiently Induce Protective Antiviral Immunity (1998) (214)
Mechanisms of Neonatal Mucosal Antibody Protection1 (2006) (211)
The influence of virus structure on antibody responses and virus serotype formation. (1996) (211)
Induction of long-lived germinal centers associated with persisting antigen after viral infection (1996) (209)
On the Key Role of Secondary Lymphoid Organs in Antiviral Immune Responses Studied in Alymphoplastic (aly/aly) and Spleenless (Hox11− /−) Mutant Mice (1997) (209)
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice (1996) (209)
Inverse correlation between IL‐7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation (2005) (206)
T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. (1989) (205)
T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I- restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? (1986) (203)
Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide (1990) (197)
Transplantation tolerance from a historical perspective (2001) (194)
Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. (1995) (194)
H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. (1976) (193)
Bystander Activation of Cytotoxic T Cells: Studies on the Mechanism and Evaluation of In Vivo Significance in a Transgenic Mouse Model (1997) (191)
Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. (1998) (187)
Viral and Bacterial Infections Interfere with Peripheral Tolerance Induction and Activate CD8+ T Cells to Cause Immunopathology (1998) (187)
Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. II. "Specificities" of the natural killer cells. (1979) (185)
Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon-α/β during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus (1997) (184)
Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis (1997) (183)
T helper cell‐independent neutralizing B cell response against vesicular stomatitis virus: Role of antigen patterns in B cell induction? (1995) (183)
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. (2006) (182)
Polyclonal and specific antibodies mediate protective immunity against enteric helminth infection. (2008) (180)
Perforin dependence of natural killer cell‐mediated tumor control in vivo (1995) (179)
T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. (1998) (179)
Protective T Cell–Independent Antiviral Antibody Responses Are Dependent on Complement (1999) (178)
CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions (1996) (178)
Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection (1997) (176)
IL-12 is not required for induction of type 1 cytokine responses in viral infections. (1999) (176)
A non-retroviral RNA virus persists in DNA form (1997) (175)
A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3 (2011) (172)
Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled (1977) (170)
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8 (2008) (170)
T-cell-mediated immunopathology in viral infections. (1974) (169)
On cross‐priming of MHC class I‐specific CTL: rule or exception? (2002) (160)
IgA production without μ or δ chain expression in developing B cells (2001) (158)
IgD can largely substitute for loss of IgM function in B cells (1998) (155)
Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? (1997) (155)
Viral persistence in vivo through selection of neutralizing antibody-escape variants. (2000) (153)
Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. (2000) (152)
Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors (2008) (152)
Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. (1997) (151)
Aplastic Anemia Rescued by Exhaustion of Cytokine-secreting CD8+ T Cells in Persistent Infection with Lymphocytic Choriomeningitis Virus (1998) (148)
Recombination of Retrotransposon and Exogenous RNA Virus Results in Nonretroviral cDNA Integration (2009) (146)
Immune responses in the absence of costimulation: viruses know the trick. (1998) (145)
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus (1986) (145)
Intralymphatic immunization enhances DNA vaccination (2001) (145)
Protective ‘immunity’ by pre‐existent neutralizing antibody titers and preactivated T cells but not by so‐called ‘immunological memory’ (2006) (143)
Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice. (1989) (143)
Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. (1993) (142)
Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells. (1993) (141)
Restriction specificities, alloreactivity, and allotolerance expressed by T cells from nude mice reconstituted with H-2-compatible or - incompatible thymus grafts (1980) (140)
Major histocompatibility complex – dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease (1989) (140)
Targeted Inactivation of the Tetraspanin CD37 Impairs T-Cell-Dependent B-Cell Response under Suboptimal Costimulatory Conditions (2000) (138)
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses (2006) (137)
Distinct sequence of negative or positive selection implied by thymocyte T-cell receptor densities (1990) (137)
On differences between immunity and immunological memory. (2002) (136)
Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model. (1994) (134)
Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoprotein (1989) (134)
T‐Cell‐Mediated Immunopathology in Viral Infections (1974) (134)
Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies (1997) (133)
Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity (1996) (132)
On immunological memory. (2000) (131)
Virus-induced autoantibody response to a transgenic viral antigen (1990) (130)
H-2 restriction of virus-specific T-cell-mediated effector functions in vivo. II. Adoptive transfer of delayed-type hypersensitivity to murine lymphocytic choriomeningits virus is restriced by the K and D region of H-2 (1976) (129)
Presentation of endogenous viral proteins in association with major histocompatibility complex class II: On the role of intracellular compartmentalization, invariant chain and the TAP transporter system (1995) (127)
Major transplantation antigens, viruses, and specificity of surveillance T cells. (1977) (126)
Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice (1995) (126)
CYTOTOXIC THYMUS-DERIVED LYMPHOCYTES IN CEREBROSPINAL FLUID OF MICE WITH LYMPHOCYTIC CHORIOMENINGITIS (1973) (126)
Identification of an N-Terminal Trimeric Coiled-Coil Core within Arenavirus Glycoprotein 2 Permits Assignment to Class I Viral Fusion Proteins (2006) (125)
IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-γ and Nitric Oxide Synthetase 21 (2000) (125)
Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. (1992) (124)
On T Cell Memory: Arguments for Antigen Dependence (1996) (120)
H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers (1977) (120)
Effects of Promyelocytic Leukemia Protein on Virus-Host Balance (2002) (119)
Lymphocyte‐mediated Cytotoxicity in vitro and in vivo: Mechanisms and Significance (1995) (116)
On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. (1980) (115)
Class II major histocompatibility complex‐restricted T cell function in CD4‐deficient mice (1994) (115)
Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice (1989) (113)
Immunological memory: lessons from the past and a look to the future (2016) (113)
Early type I interferon‐mediated signals on B cells specifically enhance antiviral humoral responses (2006) (112)
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice. (1999) (112)
Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. (1986) (109)
Peptide‐induced T cell receptor down‐regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation (1997) (109)
The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. (1996) (109)
Intrathymic elimination of Mlsa-reactive (V beta 6+) cells during neonatal tolerance induction to Mlsa-encoded antigens (1988) (108)
TAP1‐independent loading of class I molecules by exogenous viral proteins (1995) (108)
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. (2000) (107)
Natural IgE production in the absence of MHC Class II cognate help. (2006) (107)
Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen‐presenting cells (1993) (107)
B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome (1990) (106)
Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D (1985) (106)
Immunity to viruses in B cell‐deficient mice: Influence of antibodies on virus persistence and on T cell memory (1996) (105)
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. The H-2K structure involved is coded by a single cistron defined by H-2Kb mutant mice (1976) (105)
Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections (2009) (105)
Postnatal disappearance of self-reactive (V beta 6+) cells from the thymus of Mlsa mice. Implications for T cell development and autoimmunity (1989) (104)
Acute rejection of vascular heart allografts by perforin‐deficient mice (1995) (104)
Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells. (1994) (103)
Vaccination for disease. (1991) (101)
Deliberate removal of T cell help improves virus-neutralizing antibody production (2004) (101)
Lymphocytic choriomeningitis virus and immunology. (2002) (100)
Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells. (1999) (100)
Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. (1998) (99)
On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells. (1999) (99)
Impairment of Cd4+ T Cell Responses during Chronic Virus Infection Prevents Neutralizing Antibody Responses against Virus Escape Mutants (2001) (99)
Direct quantitation of rapid elimination of viral antigen‐positive lymphocytes by antiviral CD8+ T cells in vivo (2000) (99)
Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses (1993) (98)
Restriction by H-2 gene complex of transfer of cell-mediated immunity to Listeria monocytogenes (1974) (98)
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon (1994) (97)
Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. (1993) (97)
Induction of protective cytotoxic T cells with viral proteins (1994) (97)
On Immunity Against Infections and Vaccines: Credo 2004 (2004) (97)
Antiviral immunity. (1997) (97)
Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus. (1995) (96)
IgA production without mu or delta chain expression in developing B cells. (2001) (95)
T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. (1993) (95)
T and B cell Tolerance and Responses to Viral Antigens in Transgenic Mice: Implications for the Pathogenesis of Autoimmune versus Immunopathological Disease (1991) (93)
Molecular analysis of the antigen receptor of virus‐specific cytotoxic T cells and identification of a new Vα family (1987) (92)
A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro (1997) (92)
Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic Cells1 (2001) (92)
Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus (1995) (92)
What is missing in immunology to understand immunity? (2000) (92)
Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus. (1986) (91)
In vitro selection of lymphocytic choriomeningitis virus escape mutants by cytotoxic T lymphocytes. (1991) (88)
Effector T‐Cell Induction and T‐Cell Memory versus Peripheral Deletion of T Cells (1993) (88)
Perforin‐independent regulation of dendritic cell homeostasis by CD8+ T cells in vivo: implications for adaptive immunotherapy (2001) (88)
Neutralizing antiviral antibody responses (2001) (87)
Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon‐I‐dependent manner in mice (2010) (86)
Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras. (1989) (86)
Preferential positive selection of Vα2+CD8+ T cells in mouse strains expressing both H‐2k and T cell receptor Vαa haplotypes: determination with a Vα2‐specific monoclonal antibody (1992) (86)
Cytotoxic T cell clone‐specific monoclonal antibodies used to select clonotypic antigen‐specific cytotoxic T cells (1985) (85)
Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. (1974) (85)
Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells (1988) (83)
CD4+ T-cell–epitope escape mutant virus selected in vivo (2001) (83)
Scrapie Pathogenesis in Subclinically Infected B-Cell-Deficient Mice (1999) (81)
Correlation of T Cell Independence of Antibody Responses with Antigen Dose Reaching Secondary Lymphoid Organs: Implications for Splenectomized Patients and Vaccine Design1 (2000) (80)
Efficient immune responses in mice lacking N‐region diversity (1995) (80)
A comparison of efficacy and specificity of three NK depleting antibodies. (1996) (79)
Maintenance of memory CTL responses by T helper cells and CD40‐CD40 ligand: antibodies provide the key (2004) (78)
Susceptibility to murine lymphocytic choriomeningitis maps to class I MHC genes—a model for MHC/disease associations (1985) (77)
Cd4+ T Cell Subsets during Virus Infection (2000) (77)
How many specific B cells are needed to protect against a virus? (1994) (76)
Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. (2005) (76)
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria. (1999) (76)
CXCR5-Dependent Seeding of Follicular Niches by B and Th Cells Augments Antiviral B Cell Responses1 (2005) (75)
Virus-specific T-cell-mediated cytotoxicity across the H–2 barrier to virus-altered alloantigen (1976) (75)
Antiviral Immune Responses in the Absence of Organized Lymphoid T Cell Zones in plt/plt Mice1 (2002) (74)
The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. (1988) (74)
Immunopathology or Organ‐Specific Autoimmunity as a Consequence of Virus Infection (1996) (74)
Antiviral Protection and Germinal Center Formation, But Impaired B Cell Memory in the Absence of CD19 (1998) (73)
T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. (1996) (73)
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. (1976) (73)
Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa (1989) (72)
Hypercholesterolemia Exacerbates Virus-Induced Immunopathologic Liver Disease Via Suppression of Antiviral Cytotoxic T Cell Responses1 (2001) (72)
Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo. (1996) (72)
Cells that express viral antigens but lack H-2 determinants are not lysed by immune thymus-derived lymphocytes but are lysed by other antiviral immune attack mechanisms. (1976) (71)
Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein (1995) (70)
H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras (1976) (70)
Experiments and Speculation on Antiviral Specificity of T and B Cells (1981) (70)
Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation (1992) (69)
Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4 (1995) (69)
Specific cytotoxic T cells eliminate cells producing neutralizing antibodies (1996) (69)
Associations between major histocompatibility antigens and susceptibility to disease. (1979) (68)
Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide (1991) (68)
Antiviral B Cell Memory in the Absence of Mature Follicular Dendritic Cell Networks and Classical Germinal Centers in TNFR1−/− Mice1 (2000) (67)
Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. (1994) (67)
"Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self. (2006) (67)
Antiviral immune responses in gene-targeted mice expressing the immunoglobulin heavy chain of virus-neutralizing antibodies (2003) (67)
Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double-deficient mice. (1996) (67)
Marginal Zone Macrophages and Immune Responses Against Viruses1 (2002) (67)
Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny (1992) (66)
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-γ (1986) (66)
Identical Vβ T-cell receptor genes used in alloreactive cytotoxic and antigen plus I–A specific helper T cells (1985) (66)
Positive and negative selection of T cell receptor V beta domains controlled by distinct cell populations in the thymus (1989) (66)
A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells (1998) (66)
Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes. (1976) (66)
Dendritic cells in autoimmune diseases. (2001) (65)
Antiviral immune responses of mice lacking MHC class II or its associated invariant chain. (1996) (65)
Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen (1994) (65)
T‐Cell Reactivity and Tolerance to Mlsa‐Encoded Antigens (1989) (63)
Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection (1998) (63)
Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major‐specific T cell lines or clones which secrete interferon‐γ and mediate parasite‐specific delayed‐type hypersensitivity (1991) (63)
Impaired Generation of Anti‐Viral Cytotoxicity against Lymphocytic Choriomeningitis and Vaccinia Virus in Mice Treated with CD4‐Specific Monoclonal Antibody (1989) (63)
Kinetics of protective antibodies are determined by the viral surface antigen. (2004) (62)
Arterial inflammation and atherosclerosis. (2002) (62)
T‐Cell Lineages, Repertoire Selection and Tolerance Induction (1988) (62)
Cell-mediated immunity to vesicular stomatitis virus infections in mice. (1978) (62)
Immunodeficiency of alymphoplasia mice (aly/aly) in vivo: structural defect of secondary lymphoid organs and functional B cell defect (2000) (62)
Antiviral immune responses in CTLA4 transgenic mice (1997) (61)
Extralymphatic virus sanctuaries as a consequence of potent T-cell activation (2007) (60)
Regulation of IgG antibody titers by the amount persisting of immune‐complexed antigen (1994) (60)
Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming (2003) (59)
Viral escape and the failure of cellular immune responses. (2000) (58)
T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses (1998) (58)
CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. (1998) (57)
Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. (1978) (55)
CD4 1 T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability (2000) (55)
Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells (2002) (55)
MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice. (1994) (55)
A monoclonal antibody against altered LFA‐1 induces proliferation and lymphokine release of cloned T cells (1986) (55)
The impact of variation in the number of CD8(+) T-cell precursors on the outcome of virus infection. (1998) (54)
Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread (2006) (54)
Distinct fates of self-specific T cells developing in irradiation bone marrow chimeras: clonal deletion, clonal anergy, or in vitro responsiveness to self-Mls-1a controlled by hemopoietic cells in the thymus (1990) (54)
Analysis of the kinetics of antiviral memory T help in vivo: characterization of short‐lived cross‐reactive T help (1990) (54)
Induction of Protective Cytotoxic T Cell Responses in the Presence of High Titers of Virus-neutralizing Antibodies: Implications for Passive and Active Immunization (1998) (54)
Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice (1998) (53)
Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma. (2003) (53)
No functional γ-chain transcripts detected in an alloreactive cytotoxic T-cell clone (1986) (52)
General and specific immunosuppression caused by antiviral T‐cell responses (1999) (52)
Primary antibody responses to a well-defined and unique hapten are not enhanced by preimmunization with carrier: analysis in a viral model. (1986) (52)
Characterization of virus‐specific cytotoxic T cell clones from allogeneic bone marrow chimeras (1987) (52)
15 – Lymphocyte–Macrophage Interactions and Macrophage Activation in the Expression of Antimicrobial Immunity in Vivo (1976) (52)
Uncertainties − discrepancies in immunology (2002) (50)
Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. (1990) (50)
Induction of optimal anti‐viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs (2000) (49)
Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus (1994) (49)
Are HIV-specific CTL responses salutary or pathogenic? (1995) (48)
Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC (2003) (48)
Characteristics of the Interaction in Vitro Between Cytotoxic Thymus‐Derived Lymphocytes and Target Monolayers Infected with Lymphocytic Choriomeningitis Virus (1974) (47)
Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions. (1993) (47)
Early appearance of sensitized lymphocytes in mice infected with Listeria monocytogenes. (1974) (47)
Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus. (1980) (46)
H-2 compatibility requirement for virus-specific T-cell-mediated cytolysis. Evaluation of the role of H-2I region and non-H-2 genes in regulating immune response (1976) (46)
An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus (1988) (46)
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. (1999) (45)
Targeting the mouse genome: a compendium of knockouts (1995) (45)
Virus neutralization by germ-line vs. hypermutated antibodies. (2000) (45)
T cell development in CD8-/- mice. Thymic positive selection is biased toward the helper phenotype. (1995) (45)
Antiinfection Immunity and Autoimmunity (2002) (44)
Skin test to assess virus-specific cytotoxic T-cell activity. (1992) (44)
Role of an Intact Splenic Microarchitecture in Early Lymphocytic Choriomeningitis Virus Production (2002) (43)
Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells (1993) (43)
Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus (1993) (42)
Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. (1990) (42)
Reactive oxygen species delay control of lymphocytic choriomeningitis virus (2013) (42)
On the role of viruses in the evolution of immune responses. (1985) (42)
Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice (1988) (42)
Pillars Article: Immunological Surveillance against Altered Self Components by Sensitised T Lymphocytes in Lymphocytic Choriomeningitis. Nature, 1974, 251: 547–548. (2004) (41)
T-cell antigen receptors with identical variable regions but different diversity and joining region gene segments have distinct specificities but cross-reactive idiotypes. (1987) (41)
Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions. (1979) (40)
Cell-mediated immune response to lymphocytic choriomeningitis and vaccinia virus in rats. (1977) (40)
Virus or a hapten‐carrier complex can activate autoreactive B cells by providing linked T help (1994) (40)
Enhanced positive selection of a transgenic TCR by a restriction element that does not permit negative selection. (1993) (39)
Immunity against solid tumors? (2001) (38)
Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. (1993) (37)
Immunity, immunopathology and vaccines against HIV? (2002) (36)
Lactate dehydrogenase-elevating virus (LDV): lifelong coexistence of virus and LDV-specific immunity. (1997) (36)
T helper cell unresponsiveness: Rapid induction in antigen‐transgenic and reversion in non‐transgenic mice (1994) (36)
Phenotypic analysis of TNFR1-deficient mice and characterization of TNFR1-deficient fibroblasts in vitro. (1994) (36)
Early Antibodies Specific for the Neutralizing Epitope on the Receptor Binding Subunit of the Lymphocytic Choriomeningitis Virus Glycoprotein Fail To Neutralize the Virus (2007) (36)
Do thymically and strictly extrathymically developing T cells generate similar immune responses? (2004) (35)
Virus-triggered AIDS: a T-cell-mediated immunopathology? (1988) (35)
Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection (1996) (35)
The concept that surveillance of self is mediated via the same set of genes that determines recognition of allogenic cells. (1977) (35)
Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice (1986) (35)
Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection. (1997) (34)
Extrathymic positive selection of αβ T-cell precursors in nude mice (1992) (34)
Induction of IgE and allergic‐type responses in fur mite‐infested mice (2006) (33)
Induced Prion Protein Controls Immune-Activated Retroviruses in the Mouse Spleen (2007) (33)
MyD88 protects from lethal encephalitis during infection with vesicular stomatitis virus (2007) (33)
Immunological memory ≠ protective immunity (2012) (33)
Selection of restriction specificities of virus-specific cytotoxic T cells in the thymus: no evidence for a crucial role of antigen- presenting cells (1982) (32)
Long‐term maternal imprinting of the specific B cell repertoire by maternal antibodies (2008) (31)
Immunodominant T cell epitope from signal sequence. (1992) (31)
Thymic selection of H-2-incompatible bone marrow cells in SCID mice. Differences in T help for induction of B cell IgG responses versus cytotoxic T cells (1988) (30)
Secondary Rearrangements and Hypermutation Generate Sufficient B Cell Diversity to Mount Protective Antiviral Immunoglobulin Responses (1999) (30)
Production of random classes of immunoglobulins in brain tissue during persistent viral infection paralleled by secretion of interleukin-6 (IL-6) but not IL-4, IL-5, and gamma interferon (1991) (30)
Specific cytotoxic T cells eliminate cells producing neutralizing antibodies (1996) (29)
Characterization of an Lyt-2+ alloreactive cytotoxic T cell clone specific for H-2Db that cross-reacts with I-Ek. (1986) (29)
Additive Effect of Neutralizing Antibody and Antiviral Drug Treatment in Preventing Virus Escape and Persistence (2000) (29)
Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo (1992) (29)
Antiviral T-cell memory? (1990) (28)
Suppression by cyclosporin A of murine T-cell-mediated immunity against viruses in vivo and in vitro. (1985) (28)
Immunogenicity of a viral model vaccine after different inactivation procedures (1994) (28)
Cell-mediated immune response to Salmonella typhimurium infection in mice: development of nonspecific bactericidal activity against Listeria monocytogenes (1976) (28)
The Nobel Lectures in Immunology The Nobel Prize for Physiology or Medicine, 1996 awarded to (1997) (28)
On observing and analyzing disease versus signals (2007) (28)
A Btk transgene restores the antiviral TI‐2 antibody responses of xid mice in a dose‐dependent fashion (1999) (28)
Peritoneal macrophages as target cells for measuring virus-specific T cell mediated cytotoxicity in vitro. (1975) (27)
Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected]. (1996) (27)
Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model (2001) (27)
Kinetics of protective antibodies are determined by the viral surface antigen (2004) (27)
Functional CD8+ but not CD4+ T cell responses develop independent of thymic epithelial MHC (2006) (27)
Development of follicular dendritic cells in lymph nodes of B-cell-depleted mice (1988) (27)
On the Role of Dendritic Cells Versus Other Cells in Inducing Protective CD8+ T Cell Responses (2014) (25)
Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge 8 (2008) (25)
Natural killer cells vs cytotoxic T cells in the peripheral blood of virus-infected mice. (1985) (25)
Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk. (1981) (25)
Identification and characterization of a novel antigen from the nematode Nippostrongylus brasiliensis recognized by specific IgE (2007) (25)
Neonatally tolerant mice fail to react against virus-infected tolerated cells (1977) (24)
Major histocompatibility complex-linked susceptibility or resistance to disease caused by a noncytopathic virus varies with the disease parameter evaluated (1989) (24)
Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology (1992) (24)
A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8+ T cell responses (2007) (23)
Donor cell persistence and activation‐induced unresponsiveness of peripheral CD8+ T cells (2000) (23)
Secondary cytotoxic cell response to lymphocytic choriomeningitis virus II. Nature and specificity of effector cells. (1976) (22)
Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology (2002) (22)
Correlation of anti-viral B cell responses and splenic morphology with expression of B cell-specific molecules. (2000) (22)
In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody. (1999) (22)
Virally induced immunosuppression. (1992) (21)
Influence of one virus infection on a second concurrent primary in vivo antiviral cytotoxic T-cell response (1983) (21)
Comparison of the sensitivity of in vivo and in vitro assays for detection of antiviral cytotoxic T cell activity. (1993) (21)
Long‐lasting immunity by early infection of maternal‐antibody‐protected infants (2009) (21)
Models for recognition of virally modified cells by immune thymus-derived lymphocytes (1976) (21)
Public versus personal serotypes of a viral quasispecies (2003) (21)
Immunity to lymphocytic choriomeningitis virus in B cell‐depleted mice: evidence for B cell and antibody‐independent protection by memory T cells (1986) (21)
Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo. (1993) (21)
Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies (1987) (21)
“Negative Vaccination” by Specific CD4+ T Cell Tolerisation Enhances Virus-Specific Protective Antibody Responses (2007) (21)
B Cell Activation State-Governed Formation of Germinal Centers following Viral Infection1 (2007) (20)
Speculations on the role of major transplantation antigens in cell-mediated immunity against intracellular parasites. (1978) (20)
Production of B Cell Stimulatory Factor-2 and Interferon Y in the Central Nervous System during Viral Meningitis and Encephalitis Evaluation in a Murine Model Infection and in Patients Brief Definitive Report (1988) (20)
Cell-mediated immunity to hepatitis-associated antigen (HAA) demonstrated by leucocyte migration test during and after acute B hepatitis. (1973) (20)
Treatment with high doses of anti-IgM prevents, but with lower doses accelerates autoimmune disease in (NZW x BXSB)F1 hybrid mice. (1987) (20)
Search for Suppression of T Cells Specific for the Second Nonhost H-2 Haplotype in F1 → P Irradiation Bone Marrow Chimeras (1979) (19)
Role of T helper cell precursor frequency on vesicular stomatitis virus neutralizing antibody responses in a T cell receptor β chain transgenic mouse (1995) (19)
Cellular Immune Recognition and the Biological Role of Major Transplantation Antigens (1997) (19)
Cellular Immune Recognition and the Biological Role of Major Transplantation Antigens (1997) (19)
Thymus function and reconstitution of immunodeficiency. (1978) (19)
Allogeneic β-islet cells correct diabetes and resist immune rejection (2002) (19)
Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help. (1989) (19)
Suppression of B cell development and antibody responses in mice with polyclonal rabbit and monoclonal rat anti-IgM antibodies. I. Characterization of the suppressed state. (1985) (18)
Immunity to infection (1991) (18)
Role of tumor necrosis factor in Listeria resistance of nude mice (2004) (18)
Felix Hoppe-Seyler Lecture 1997. Protective antibody responses against viruses. (1997) (17)
Immunization with recombinant protein: conditions for cytotoxic T cell and/or antibody induction (1994) (17)
Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus. (1987) (17)
On ‘reactivity’ versus ‘tolerance’ (2004) (17)
Cytotoxic T cell activity is strain-specific in outbred mice infected with lymphocytic choriomeningitis virus. (1975) (17)
An easy and rapid method to screen large numbers of antibodies against internal cellular determinants. (1988) (16)
Comparison of T cell-mediated immune responsiveness of NZB, (NZB x &NZW)F1 hybrid and other murine strains. (1977) (16)
Allogeneic beta-islet cells correct diabetes and resist immune rejection. (2002) (16)
LEFLUNOMIDE-MEDIATED SUPPRESSION OF ANTIVIRAL ANTIBODY AND T CELL RESPONSES: DIFFERENTIAL RESTORATION BY URIDINE1 (2001) (16)
Review: Cellular immune responses to intracellular parasites: role of the major histocompatibility gene complex and thymus in determining immune responsiveness and susceptibility to disease (1979) (16)
Effect of cyclosporin A on immunity to Listeria monocytogenes (1986) (15)
Addendum: Specific cytotoxic T cells eliminate cells producing neutralizing antibodies (1996) (15)
Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus. (1983) (15)
PROTECTIVE ANTIBODY RESPONSES AGAINST VIRUSES (1997) (15)
Suppressive effects of B-lactam-antibiotics on in vitro generation of cytotoxic T-cells. (1986) (15)
Non‐tolerant B cells cause autoimmunity in anti‐CD8 IgG2a‐transgenic mice (1996) (15)
Immunology - Promethean Viruses (1994) (15)
Restriction specificity of virus-specific cytotoxic T cells from thymectomised irradiated bone marrow chimeras reconstituted with thymus grafts. (1981) (14)
Major transplantation antigens in host responses to infection. (1978) (14)
Crystal‐ball gazing − the future of immunological research viewed from the cutting edge (2006) (13)
Correlation of tolerogenicity of a viral antigen with its immunogenicity. (1997) (13)
Treatment with anti-tumor necrosis factor alpha does not influence the immune pathological response against lymphocytic choriomeningitis virus. (1990) (13)
Enhanced tumor susceptibility of immunocompetent mice infected with lymphocytic choriomeningitis virus (2005) (12)
Mapping of the dominant neutralizing antigenic site of a virus using infected cells. (1996) (12)
„What about the evolution and adaptability of EJI?”︁ (2007) (12)
Immune Response against Lymphocytic Choriomeningitis Virus Inaction in Mice without CD 8 Expression (2003) (11)
Cell-mediated immunity to viruses in hamsters. (1978) (11)
Immunoreactivity of long lived H-2 incompatible irradiation chimeras (H-2d leads to H-2b). (1982) (11)
Immunology and immunity against infection: General rules (2005) (11)
Corrigendum: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease (2005) (11)
H-2-associated specificity of virus-immune cytotoxic T cells fromH-2 mutant and wild-type mice: M523 (H-2Kka) and M505(H-2Kbd) do, M504 (H-2Dda) and M506(H-2Kfa) do not crossreact with wild-typeH-2K orH-2D (1977) (11)
Immune Protection vs. Immunopathology vs. Autoimmunity: A Question of Balance and of Knowledge (1993) (11)
T cell-mediated immune responses of lupus-prone BXSB mice and other murine strains. (1979) (11)
Association of disease susceptibility to major histocompatibility antigens. (1979) (11)
The Role of Specific T Cell Subpopulations in Murine Cutaneous Leishmaniasis (1986) (11)
Transgenic Animal Models for Virus‐Induced Autoimmune Diseases (2000) (11)
Monoclonal antibodies against viral determinants are not restricted to the K/D end of the major histocompatibility complex (1987) (11)
Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. (1995) (10)
On the pathogenesis of perforin defects and related immunodeficiencies. (2000) (10)
Ontogeny and selection of the T cell repertoire in transgenic mice. (1989) (10)
Some general aspects of immunity to viruses. (1994) (10)
T-cell immunoincompetence in allogeneic chimerism. (1992) (10)
Natural cytotoxic cells in NZB mice: spontaneous in vivo and in vitro primed activity and structural characteristics. (1979) (10)
HLA and H-2 (1979) (10)
Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase. (1985) (10)
Immunosuppression in mice by lymphocytic choriomeningitis virus infection: time dependence during primary and absence of effects on secondary antibody responses. (1990) (9)
Role of the H-2 gene complex in cell-mediated immunity to infectious disease. (1977) (9)
Role of TCR‐restricting MHC density and thymic environment on selection and survival of cells expressing low‐affinity T cell receptors (2004) (9)
The role of antigen in maintaining T cell memory. (1994) (9)
Neonatal tolerance to MIs-1a determinants: deletion or anergy of V beta 6+ T lymphocytes depending upon MHC compatibility of neonatally injected cells. (1991) (9)
Immunology and immunity studied with viruses. (2007) (9)
Cytotoxic T cell response to lymphocytic choriomeningitis virus. Properties of precursors of effector T cells, primary effector T cells and memory T cells in vitro and in vivo. (1977) (9)
Cortisone-resistant effector T cells in acute lymphocytic choriomeningitis and Listeria monocytogenes infection of mice. (1975) (9)
Immunity to infection (1991) (9)
CD4 negative mice as a model for immunodeficiency. (1993) (9)
MHC Restriction and Cytotoxic T Lymphocytes (1984) (9)
Immunoreactivity of long lived h-2 incompatible irradiation chimeras (h-2d-h-2b). (1982) (8)
Quantitative studies of the growth and rejection of allogeneic tumour cells in mouse cerebrospinal fluid. Elimination in the absence of H-2 differences. (1975) (8)
Role of the H-2 gene complex in cell-mediated immunity to infectious disease. (1977) (8)
Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. (1990) (8)
Immunobiology of cytotoxic T-cell resistant virus variants: studies on lymphocytic choriomeningitis virus (LCMV) (1996) (8)
Cellular Immune Response to Viruses and the Biological Role of Polymorphic Major Transplantation Antigens (1979) (7)
Promethean viruses? (1994) (7)
IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-gamma and nitric oxide synthetase (2019) (7)
Role of the H-2I region in the generation of an antiviral cytotoxic T-cell response in vitro. (1980) (7)
The Challenges of an HIV Vaccine Enterprise (2004) (7)
Immune response against vaccinia virus in rhesus monkeys: no evidence for primary MHC-restricted cytolytic T cells. (1984) (7)
Extrathymic positive selection of alpha beta T-cell precursors in nude mice. (1992) (7)
Games that viruses play (1991) (7)
Viruses and virus-like agents in disease. (1993) (7)
Inhibition of hapten‐specific cytotoxic T cell recognition by monoclonal anti‐hapten antibodies (1985) (7)
The thymus: Its influence on recognition of “self major histocompatibility antigens” by T cells and consequences for reconstitution of immunodeficiency (1978) (7)
Macrophage activation in mice lacking thymus-derived (T) cells (1975) (7)
Virus-specific proliferative T-cell responses: parameters and specificity. (1980) (6)
Correlates of Protective Viruses Damaging to HIV Infection. (1996) (6)
Felix Hoppe-Seyler Lecture 1997. Protective antibody responses against viruses. (1997) (6)
Gene Technology and Democracy (1997) (6)
Fate of potentially self-reactive T cells in neonatal mice: analysis of V beta 6+ T cells in Mlsa mice. (1989) (6)
Distinct Patterns of Virus‐Specific T Cell‐Mediated Cytolysis of Transformed versus Primary Target Cells (1988) (6)
Delayed type hypersensitivity (DTH) in anti-IgM-treated B cell-depleted mice: analysis of induction and effector phase. (1988) (6)
Cell to cell interaction : international symposium, Basel, September 13-15, 1990 (1990) (6)
Immunosuppression by a noncytolytic virus via T cell mediated immunopathology. Implication for AIDS. (1995) (6)
T helpers may be sensitized by antigen-specifically altered structures, which are coded by the I region of the H-2 gene complex. (1976) (6)
Contra: CD8+ T-cell-mediated suppression without 'suppressor' T cells? (1993) (5)
Rejection of allogeneic tumor cells growing in mouse cerebrospinal fluid Functional analysis of the inflammatory process (1981) (5)
Allogeneic H-2d leads to H-2b irradiation bone marrow chimeras: a) failure to transfer chimerism adoptively and b) immune reactivity of immunocompetent lymphocytes adoptively transferred to chimeras. (1983) (5)
Protection and damage by antiviral immunity. (1993) (5)
Search for suppression of T cells specific for the second nonhost H-2 haplotype in F1 leads to P irradiation bone marrow chimeras. (1979) (5)
Host-determined T cell fine specificity for self-H-2 in radiation bone-marrow chimeras of standard C57BL/6 (H-2b) mutantHz1 (H-2ba), and F1 mice (1978) (5)
Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera. (1993) (5)
Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines (1986) (5)
Thymus function and reconstitution of immunodeficiency. (1978) (5)
Ultrastructure of normal and abnormal bone repair (2005) (5)
Tolerance to Mlsa by clonal deletion of V beta 6+ T cells in bone marrow and thymus chimeras. (1989) (5)
Identical V beta T-cell receptor genes used in alloreactive cytotoxic and antigen plus I-A specific helper T cells. (1985) (5)
Response: immunology taught by darwin. (1996) (4)
Major histocompatibility gene complex‐disease associations may reflect T cell‐mediated immunopathology (1986) (4)
THE ROLE OF MAJOR HISTOCOMPATIBILITY ANTIGENS IN CELL-MEDIATED IMMUNITY TO VIRUS INFECTIONS (1976) (4)
Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology. (2001) (4)
On plasma cell longevity or brevity (2014) (4)
Assessing the mechanisms that give rise to autoimmunity. (2000) (4)
Localization of T helper cell epitopes in the vesicular stomatitis virus: the nucleoprotein is responsible for serotype cross-reactive T help. (1994) (4)
Virus-induced acquired immune suppression by cytotoxic T cell-mediated immunopathology. (1992) (4)
Major transplantation antigens in T cell-mediated immunity: a comparison of the transplantation reaction with antiviral immunity. (1978) (4)
Inhibition of HSV-1 and vaccinia virus replication by cephalosporin derivatives. (1988) (4)
Virus-immune cytotoxic T cells are sentized to by virus specifically altered structures coded for in H-2K or H-2D: a biological role for major histocompatibility antigens. (1976) (3)
T cells causing immunological disease: immunopathology or autoimmunity? (1992) (3)
The 1995 Albert Lasker Medical Research Award. MHC-restricted T-cell recognition. The basis of immune surveillance. (1995) (3)
Immunological tolerance to a non-cytopathic virus is not inheritable in mice. (1984) (3)
Immunity 2000. (2000) (3)
The role of the H-2 gene complex in cell-mediated immunity to viral and bacterial infections in mice (1975) (3)
Passive oral immunization with bovine immunoglobulins: EnteropathogenicEscherichia coli from infants and bovine anti-E. coli lactoserum assayed in the rabbit ileal loop model (1975) (3)
Graft-versus-host reactions in F1 hybrid mice: MHC-restriction-independent generalized depression of virus-specific cytotoxic T cell response. (1984) (3)
Variable immune response against a developmentally regulated self-antigen. (1999) (3)
Immune-Protection Versus Immunopathology by Antiviral T Cell Responses (1989) (3)
Protection and damage by antiviral immunity. (1993) (3)
Low responsiveness to Dk or Db plus vaccinia virus or to Kk plus lymphocytic choriomeningitis virus assessed by availability of D or K products. (2008) (3)
Thymocyte Selection and Peripheral Tolerance Using the Lymphocytic Choriomeningitis Virus as a Model Antigen (1994) (3)
Generation of virus-specific cytolytic activity in human peripheral lymphocytes after vaccination with vaccinia virus and measles virus (1978) (2)
Part C - Immunological Memory and Vaccines against Acute Cytopathic and Noncytopathic Infections (2003) (2)
Requirement for Neutralizing Antibodies to Control Bone Marrow Transplantation-Associated Persistent Viral Infection and to Reduce Immunopathology1 (2005) (2)
The 1995 Albert Lasker Medical Research Award. MHC-restricted T-cell recognition. The basis of immune surveillance. (1995) (2)
Responses to Cohn's Discussion on the Zinkernagel–Hengartner ‘Credo 2004’ (2005) (2)
[Gold phagocytosis by the chondrocytes of articular cartilage and menisci]. (1972) (2)
Kinetics of clonal deletion varies with tolerizing antigen. (1992) (2)
Activation or suppression of bactericidal activity of macrophages during a graft-versus-host reaction againstI-A andI-J-region differences, respectively (2005) (2)
Viral immunopathology. Introduction. (1995) (2)
HIV. Games that viruses play. (1991) (2)
erratum: Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction (2001) (2)
Restriction specificity of virus-specific cytotoxic T cells from thymectomised irradiated bone marrow chimeras reconstituted with thymus grafts. (1981) (2)
DOES THE APPARENT H-2 COMPATIBILITY REQUIREMENT FOR VIRUS-SPECIFIC T CELL-MEDIATED CYTOLYSIS REFLECT T CELL SPECIFICITY FOR “ALTERED SELF” OR PHYSIOLOGICAL INTERACTION MECHANISMS? (1976) (2)
Positive and negative selection of the T-cell antigen receptor repertoire in nontransgenic mice. (1989) (1)
Specificity of natural killer (nk) cells induced in mice by lcm virus. Abstr. (1978) (1)
Proceedings: Immunosuppression by embryonic liver cells: a model for establishment of tolerance to self. (1975) (1)
Gene cloning in organisms other than E. coli. (1982) (1)
Novartis Prizes for Immunology 2001, Stockholm (2002) (1)
Suppression of the generation of secondary virus-specific proliferative and cytotoxic T lymphocytes by suppressor cells induced during primary anti-viral sensitization in vitro. (1981) (1)
Immunity to infection. (1991) (1)
Infections, Immunity, and Autoimmunity (2006) (1)
Viruses and virus-like agents in disease : 2nd Karger symposium, Basel, March 7-9, 1993 (1993) (1)
How to escape immune surveillance? (2004) (1)
The question of derepression ofH-2 specificities in virus-infected cells: Failure to detect specific alloreactive T cells after systemic virus infection or alloantigens detectable by alloreactive T cells on virus-infected target cells (1977) (1)
Differentiation of T cells: thymic selection of specificity for self. (1982) (1)
What is the most important achievement in viral immunology in the last five years (1995) (1)
How does a viral infection trigger an autoimmune disease (1995) (1)
Biological role of major transplantation antigens in T cell self-recognition (1986) (1)
Dear Readers and Authors of the European Journal of Immunology (2005) (1)
Mechanisms of virus-induced autoimmune disease (2000) (1)
ProtectionMechanisms of Neonatal Mucosal Antibody (2006) (1)
Absence of complement receptor type 3 and lymphocyte function antigen 1 causing deficient phagocyte and lymphocyte functions (1988) (1)
Of mice and men: cytotoxic T cells and AIDS pathogenesis. (1999) (1)
Absence of effects of thymopentin on murine host resistance to Listeria monocytogenes. (1991) (1)
Expression of T cell receptor gamma-chain in murine cytotoxic T cells: analysis of a highly transcribed nonrearranged gene cluster. (1988) (1)
Anti-Listeria monocytogenes immunity in μ-suppressed mice: a comparison of treatment with conventional hyperimmune rabbit anti-mouse IgM and affinity-purified, monoclonal rat anti-mouse IgM (2004) (1)
No B cell tolerance, but generation of antibody escape mutants in vivo in anti-lymphocytic choriomeningitis virus specific antibody transgenic mice (1997) (1)
Effect of Cell Dose and Dose of Infectious Agent on Expression of Protection Against Listeria monocytogenes and Ectromelia Virus in Cell Transfer Models (1975) (1)
Thymic MHC class I gene regulation of susceptibility to lymphocytic choriomeningitis. (1990) (1)
BETWEEN MAJOR HISTOCOMPATIBILI TY ANTIGENS AND SUSCEPTIBILITY TO DISEASE (1979) (1)
WHAT ABOUT MHC RESTRICTED T CELLS (1980) (1)
No functional gamma-chain transcripts detected in an alloreactive cytotoxic T-cell clone. (1986) (1)
EPITOPE REPETITIVENESS AS A SELF NONSELF DISCRIMINATOR FOR B-CELLS (1995) (1)
Protection and damage by immunity to intracellular parasites. (1983) (1)
General immunologic fundamentals and an example of virally induced immunosuppression (1991) (1)
[Role of virus-induced cell-mediated immune reactions]. (1981) (1)
[Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?]. (1994) (1)
[Virus-induced immune deficiency disease AIDS: direct pathogenic effect of the virus or immunopathology?]. (1994) (1)
[General immunologic fundamentals and an example of virally induced immunosuppression]. (1991) (1)
Immune Response against Lymphocytic Choriomeningitis Virus Inaction in Mice without CD8 Expression By Wai-Ping Fung-Leung,* Thomas M. Ktindig, t (1991) (1)
About the Discovery of MHC-restricted T Cell Recognition (1995) (1)
On the pathogenesis of perforin defects and related immunodeficiencies. (2000) (0)
What are the major goals of research in viral immunology (1995) (0)
Subject Index, Vol. 35, 1993 (1993) (0)
Response : Vaccination, Immunopathology, and Immunity (1991) (0)
Is immunization with naked DNA the most important factor in the development of vaccines (1995) (0)
Laudatio Jean Paul Thiery (1990) (0)
Cytotoxic T Cells Are Sensitised to ‘Altered Self’ in Lymphocytic Choriomeningitis Virus Infections (1975) (0)
How Strict Is the MHC Restriction of T Cells (1981) (0)
Murine antiviral proliferative and cytotoxic T-cell responses: specificities and role of the H-21 region. (1981) (0)
IMMUNOLOGY BY VIRUSES (1993) (0)
Evidence for a role of IFN γ in control ofListeria monocytogenes in T cell deficient mice (1991) (0)
Cell-mediated immunity in autoimmune mice. Abstr. (1978) (0)
Virus-Induced Acquired Immunosuppression by T-Cell-Mediated Immunopathology and Vaccine Strategies (1993) (0)
Recombinant vaccines (1991) (0)
Protectionof Neonatal Mucosal Antibody (2013) (0)
Science and sensibility: an interview with Professor Rolf M. Zinkernagel, Nobel Prize Winner for Medicine 1996. Interview by Hrishikesh Satish Kulkarni and Ajit H. Goenka. (2007) (0)
Nobel Prizes Awarded ; Discoveries in Immunology , Fullerene Chemistry and Superfluidity Recognized (1997) (0)
Antibody Protection Mechanisms of Neonatal Mucosal (2010) (0)
Contents, Vol. 83, Supplement 1, 1987 (1987) (0)
11 Helminthen: 11.1 Trematoda (Saugwürmer) (2010) (0)
A process for preparing agents for the therapy of transmissible spongiform encephalopathy and non-infectious blood and tissue products, and the products produced (1997) (0)
Early nonspecific cell mediated cytotoxicity in mice infected with lymphocytic choriomeningitis virus (lcmv). Abstr. (1977) (0)
Correlates of Protective Viruses Damaging to HIV Infection (1996) (0)
[Role of virus-induced cell-mediated immune reactions]. (1981) (0)
elimination of CD4+ T cells prevents fetal allograft rejection in mice after LCMV virus infection (1989) (0)
Regulation of Immune Response to Infectious Agents (1987) (0)
AntiviralNiches by B and Th Cells Augments CXCR 5-Dependent Seeding of Follicular (2005) (0)
Response from Zinkernagel et al (1997) (0)
Immunity to infection: Editorial overview (1992) (0)
Protection and damage by immunity to intracellular parasites. (1983) (0)
Diagnosis of transmissible spongiform encephalopathy (1997) (0)
Viruses Escaping Immunological Surveillance (1993) (0)
T cells causing immunological disease (2004) (0)
New use of HIV protease inhibitors (1999) (0)
Studies on immunity to lymphocytic choriomeningitis virus (2005) (0)
arenavíricos vectors replication defective (2008) (0)
Contents, Vol. 42, 1975 (1975) (0)
Reactivity and tolerance of virus-specific T cells. (1989) (0)
MHC-Disease Associations and T Cell-Mediated Immunopathology (1988) (0)
plt/plt Mice of Organized Lymphoid T Cell Zones in Antiviral Immune Responses in the Absence (2013) (0)
Assessment of some genetic non-MHC differences with GVHR-induced anti-listeria activity of macrophages (2004) (0)
Professor A. Grumbach 1895-1975 (1975) (0)
Author index (1999) (0)
Peptide-antigen treatment of naive and memory CTL: Antigen-specific tolerization versus immunopathology (1997) (0)
Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
MHC-RESTRICTION AND DIFFERENTIATION OF T CELLS1 (1979) (0)
Virus-induced Transient Bone Marrow Aplasia: Major Role of Interferon- (cid:97) / (cid:98) during Acute Infection with the Noncytopathic Lymphocytic Choriomeningitis Virus (1997) (0)
Immunologic cellular effector mechanisms as examples of cellular interactions. (1978) (0)
[Transplantation antigens: biological function and role as disease determinants]. (1982) (0)
Immune surveillance against a so immunological ignorance (2016) (0)
Immunogenetics: In the forefront (1999) (0)
Differentiation of T cells: thymic selection of specificity for self. (1982) (0)
10 Protozoen: 10.8 Isospora, Cyclospora, Sarcocystis (2010) (0)
Vaccine Design Implications for Splenectomized Patients and Reaching Secondary Lymphoid Organs: Antibody Responses with Antigen Dose Correlation of T Cell Independence of (2000) (0)
Response to 'Lack of IgA in Cμ-deficient patients' (2002) (0)
Is HIV-induced AIDS a T-cell mediated immunopathology? (1994) (0)
Anti-TIRC7 Antibody Treatment Prevents Rejection of Mice Cardiac Allografts while Immune Competency to Viral and Bacterial Antigens Remain Normal (2018) (0)
Different viewpoints on trap-sterilize-release programs. (1996) (0)
[Problems of laundry disinfection. I. Sterilization]. (1962) (0)
H-2, Thymus and H-2 Restricted T Cells (1978) (0)
Immunodominant T Cell Epitope from Signal Sequence (1992) (0)
[Adherence of pathogenic Escherichia coli to epithelial cells isolated from the intestinal mucosa of the rabbit, inhibiting effect of hyperimmune bovine colostrum and of various carbohydrates (author's transl)]. (1975) (0)
Response : Immunology Taught by Darwin (1996) (0)
Using modulators of proteasome compounds in therapy (1998) (0)
[Model concepts on the development of so-called autoimmune diseases]. (1993) (0)
[Ultrastructural studies of the juxtaepiphyseal capillaries after perfusion fixation]. (1972) (0)
[Autoimmune diseases]. (1993) (0)
POSSIBLE FUNCTION OF H-2 CODED CELL-SURFACE MARKERS: H-2 STRUCTURES ARE RECEPTORS FOR DIFFERENTIATION SIGNALS (1978) (0)
Protection T Cell-Mediated Antiviral + for CD4 Qualitative and Quantitative Requirements (1999) (0)
Virus-induced immunosuppression: edited by S. Specter, M. Bendinelli and H. Friedman, Plenum Press, 1989. $79.50 (xxii + 477 pages) ISBN 0 306 43040 1 (1990) (0)
[Cartilage mineralization following circumscript lesion of the tibial epiphyseal plate in rats (contribution to the clarification of the role of lysosomes in chondrocytes)]. (1971) (0)
A New Method of controlling Mosquito Larvae. (1946) (0)
[Distal types of plexus brachialis neuritis]. (1970) (0)
Formalin Inactivation ofVesicular Stomatitis VirusImpairs T-Cell- butNotT-Help-Independent (1993) (0)
Decreased Tumor Surveillance in Perforin-deficie nt Mice By Maries E van den Broek,* David K~igi, Ferry Ossendorpfl Ren6 Toesfi SpirosVamvakas,~ Werner K. Lutz,~ Cornelis J.M. Melieffl (1996) (0)
Biological Role of Major Transplantation Antigens in T Cell Self-recognition: Possible Consequences in Clinical Medicine (1986) (0)
Visual izat ion , Character izat ion , and Turnover (2003) (0)
Activity of VSV-specific scFv reagents in vitro and in vivo 2801 (2001) (0)
New use of compounds which inhibit HIV protease. (1999) (0)
How can we stimulate the immune system in vivo? (1992) (0)
T-cell-mediated immunopathology versus • ly'by " ' " ' direct cyto sis virus: implications for (1994) (0)
for CD4+ T Cell-Mediated Antiviral Qualitative and Quantitative Requirements (2013) (0)
Science and sensibility: An interview with professor Rolf M. Zinkernagel, Novel Prize winner for medicine 1996 (2007) (0)
interferon . virus to alpha / beta interferon and to gamma Resistance of lymphocytic choriomeningitis (0)
Nitric Oxide Synthetase 2 and γ Infection with a Limited Role of IFN-Protection Against Acute Vaccinia Virus IL-4 and IL-10 Antagonize IL-12-Mediated and (1999) (0)
Immunological memory ≠ protective immunity (2012) (0)
Evidence that virus-immune cytotoxic t cells are effectors in vivo. Abstr. (1976) (0)
Cloned cytotoxic T cells specific for lymphocytic choriomeningitis virus induce acute disease and primary footpad swelling in infected mice (2005) (0)
Title Page / Contents / Publisher’s Note (1990) (0)
Viruses Know the Trick Responses in the Absence of Costimulation: Cutting Edge Commentary: Immune (1998) (0)
Acrucial role forBcells in neuroinvasivescrapie (0)
Responses to Cohn's Discussion on the Zinkernagel–Hengartner ‘Credo 2004’ (2005) (0)
Restimulation Via Dendritic Cells Is Most Efficiently Maintained by Protective Antiviral Cytotoxic T Cell Memory (1999) (0)
Reply to 'On the implications of polyclonal B cell activation' (2003) (0)
Tolerance, Autoimmunity and Immunopathology (1993) (0)
T cell therapeutics for transmissible spongiform encephalopathy and method for the production of non-infectious blood products and tissues derived products (1997) (0)
Immune surveillance and AIDS progression (1997) (0)
Cytotoxic T Cell Responses Disease Via Suppression of Antiviral Virus-Induced Immunopathologic Liver Hypercholesterolemia Exacerbates (2001) (0)
UNDERSTANDING MICROBIAL PATHOGENESIS AS A BASIS FOR VACCINE DESIGN (2003) (0)
RECOGNITION BY T-LYMPHOCYTES: INFERENCES FROM FUNCTIONAL STUDIES (1981) (0)
Response from Oehen and Zinkernagel (1993) (0)

This paper list is powered by the following services:

Other Resources About Rolf M. Zinkernagel

en.wikipedia.org

What Schools Are Affiliated With Rolf M. Zinkernagel?

Rolf M. Zinkernagel is affiliated with the following schools:

Image Attributions

Image Source for Rolf M. Zinkernagel